VIGIL NEUROSCIENCE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.71 USD | +5.04% |
|
-3.90% | -19.82% |
Chart calendar Vigil Neuroscience, Inc.
dc55385b78d8.y3YIKfrG6cuUXzBiFPsJYmbkYsz2k4HXkJAVv_nrTHs.8yY7H5yZra7lPGIbJcI7VgiwEbagp_mC-PJw6JW9YSuYKTBijY-8kcIrAA~c809896fac66f425a7e719c723d159d8
Upcoming events on Vigil Neuroscience, Inc.
Past events on Vigil Neuroscience, Inc.
| 2024-04-17 15:48 | American Academy of Neurology Meeting |
| 2024-04-17 10:00 | American Academy of Neurology Meeting - Poster No : 013 |
| 2024-04-14 19:30 | American Academy of Neurology Meeting - Poster No : 001 |
| 2024-03-26 07:05 | Q4 2023 Earnings Release |
| 2024-03-19 15:30 | Stifel CNS Day |
| 2024-03-06 09:30 | Alzheimer and Parkinson Diseases International Conference - Presentation Session: 2780 |
| 2024-02-29 18:00 | ACTRIMS Forum - Poster #: P126 |
| 2024-02-08 13:30 | Guggenheim Healthcare Talks Biotechnology Conference |
| 2024-01-11 10:30 | JPMorgan Healthcare Conference |
| 2023-11-28 15:50 | Evercore ISI HealthCONx Conference |
| 2023-11-16 16:30 | VGL101 IGNITE Phase 2 Trial Results Call |
| 2023-11-07 07:05 | Q3 2023 Earnings Release |
| 2023-10-12 13:30 | Jefferies Inaugural Biotech CNS/Neuro Summit |
| 2023-09-13 07:30 | R&D Day |
| 2023-09-11 09:20 | Morgan Stanley Global Healthcare Conference - Fireside Chat |
| 2023-08-08 07:05 | Q2 2023 Earnings Release |
| 2023-06-08 09:00 | Jefferies Global Healthcare Conference |
| 2023-06-07 08:00 | Annual General Meeting |
| 2023-05-15 | Mizuho Neuroscience Summit |
| 2023-05-10 07:00 | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -68,8 -71,9 4.27% | -88,5 -92,2 4.05% | -110 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -42,4 -46,2 8.27% | -68,9 -69,9 1.46% | -88,9 -88,7 -0.16% | -103 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -43,3 -46,9 7.78% | -68,3 -70,1 2.62% | -82,6 -84,6 2.32% | -98,1 |
|
Net income Million USD | Released Forecast Spread | -28,5 | -43,3 -46,9 7.78% | -68,3 -69,8 2.14% | -82,6 -83,7 1.24% | -96,8 |
|
EPS USD | Released Forecast Spread | -21,2 | -28,3 -2,48 -1041.05% | -2,16 -2,24 3.71% | -2,13 -2,10 -1.49% | -2,17 |
| Announcement Date | 08/10/21 | 25/03/22 | 21/03/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -13,0 -16,8 22.91% | -15,3 -16,6 7.82% | -17,0 -18,6 8.38% | -17,6 -18,7 5.74% | -18,9 -19,5 3.24% | -20,8 -19,8 -5% | -21,9 -20,8 -5.13% | -22,3 -22,6 1.03% | -23,9 -23,1 -3.15% | -24,5 | -25,3 | -25,6 | -26,1 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,0 -16,6 21.93% | -15,3 -16,5 7.25% | -17,0 -18,5 8.03% | -17,5 -18,9 7.28% | -18,5 -19,7 6.2% | -19,8 -20,1 1.57% | -20,2 -21,4 5.55% | -20,5 -23,3 11.91% | -22,2 -23,8 6.75% | -23,9 | -25,2 | -23,4 | -24,3 | |
|
Net income Million USD | Released Forecast Spread | -13,0 -16,6 21.93% | -15,3 -16,5 7.25% | -17,0 -18,5 8.03% | -17,5 -18,6 6.04% | -18,5 -19,4 4.81% | -19,8 -19,7 -0.68% | -20,2 -20,7 2.55% | -20,5 -22,4 8.63% | -22,2 -22,7 2.4% | -23,6 | -24,7 | -23,3 | -24,0 | |
|
EPS USD | Released Forecast Spread | -8,28 -0,78 -957.03% | -0,58 -0,58 0.57% | -0,60 -0,64 6.61% | -0,53 -0,60 12.15% | -0,48 -0,58 17.48% | -0,51 -0,54 5.3% | -0,52 -0,54 4.21% | -0,53 -0,56 5.78% | -0,57 -0,54 -6.05% | -0,61 | -0,60 | -0,51 | -0,51 | |
| Announcement Date | 25/03/22 | 12/05/22 | 08/08/22 | 10/11/22 | 21/03/23 | 10/05/23 | 08/08/23 | 07/11/23 | 26/03/24 | - | - | - | - | - |
| Today 16:05 | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Vigil Neuroscience, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VIGL Stock
- Calendar Vigil Neuroscience, Inc.
